Identifying Etiologically Distinct Sub-Types of Cancer: A Demonstration Project Involving Breast Cancer

Establishment of the Cancer Prevention Study II Nutrition Cohort Colorectal Tissue Repository

(2014) P. T. Campbell et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

A new clinical cut-off of cytokeratin 19 mRNA copy number in sentinel lymph node better identifies patients eligible for axillary lymph node dissection in breast cancer

(2014) Cristina Deambrogio et al.   JOURNAL OF CLINICAL PATHOLOGY

The detection of ESR1/PGR/ERBB2 mRNA levels by RT-QPCR: a better approach for subtyping breast cancer and predicting prognosis

(2013) Xin Du et al.   BREAST CANCER RESEARCH AND TREATMENT

Regulation of Cell Proliferation and Migration by Keratin19-Induced Nuclear Import of Early Growth Response-1 in Breast Cancer Cells

(2013) J.-h. Ju et al.   CLINICAL CANCER RESEARCH

Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host and disease

(2013) Shuji Ogino et al.   MODERN PATHOLOGY

A conceptual and methodological framework for investigating etiologic heterogeneity

(2013) Colin B. Begg et al.   STATISTICS IN MEDICINE

Detecting and Exploiting Etiologic Heterogeneity in Epidemiologic Studies

(2012) C. B. Begg et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Comprehensive molecular portraits of human breast tumours

(2012) Daniel C. Koboldt et al.   NATURE

Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger

(2011) Mia M. Gaudet et al.   BREAST CANCER RESEARCH AND TREATMENT

History of parvovirus B19 infection is associated with a DNA methylation signature in childhood acute lymphoblastic leukemia

(2011) Gisele M. Vasconcelos et al.   Epigenetics

Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium

(2011) Annegien Broeks et al.   HUMAN MOLECULAR GENETICS

Receptors, Associations, and Risk Factor Differences by Breast Cancer Subtypes: Positive or Negative?

(2011) L. Bernstein et al.   JNCI-Journal of the National Cancer Institute

Reproductive history and risk of three breast cancer subtypes defined by three biomarkers

(2010) Amanda I. Phipps et al.   CANCER CAUSES & CONTROL

DNA methylation profiles delineate etiologic heterogeneity and clinically important subgroups of bladder cancer

(2010) C.S. Wilhelm-Benartzi et al.   CARCINOGENESIS

Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field

(2010) S. Ogino et al.   GUT

A strategy for distinguishing optimal cancer subtypes

(2010) Colin B. Begg   INTERNATIONAL JOURNAL OF CANCER

Incidence of Breast Cancer and Its Subtypes in Relation to Individual and Multiple Low-Penetrance Genetic Susceptibility Loci

(2010) Gillian K. Reeves et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies

(2010) Xiaohong R. Yang et al.   JNCI-Journal of the National Cancer Institute

Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy

(2010) Jordi Barretina et al.   NATURE GENETICS

The molecular pathology of cancer

(2010) Timothy J. R. Harris et al.   Nature Reviews Clinical Oncology

Breast Cancer DNA Methylation Profiles Are Associated with Tumor Size and Alcohol and Folate Intake

(2010) Brock C. Christensen et al.   PLoS Genetics

Is There a Difference in the Association between Percent Mammographic Density and Subtypes of Breast Cancer? Luminal A and Triple-Negative Breast Cancer

(2009) H. Ma et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinoma

(2009) Carmen J. Marsit et al.   CARCINOGENESIS

Dietary folate, alcohol and B vitamins in relation to LINE-1 hypomethylation in colon cancer

(2009) E. S. Schernhammer et al.   GUT

Prognostic Value of the Molecular Detection of Circulating Tumor Cells Using a Multimarker Reverse Transcription-PCR Assay for Cytokeratin 19, Mammaglobin A, and HER2 in Early Breast Cancer

(2008) M. Ignatiadis et al.   CLINICAL CANCER RESEARCH

Genetic Susceptibility Loci for Breast Cancer by Estrogen Receptor Status

(2008) M. Garcia-Closas et al.   CLINICAL CANCER RESEARCH

Direct multiplexed measurement of gene expression with color-coded probe pairs

(2008) Gary K Geiss et al.   NATURE BIOTECHNOLOGY